Giving Immunotherapies the Green Light to Attack

News   Apr 05, 2017 | Original story from UNC Lineberger Comprehensive Cancer Center

 
Giving Immunotherapies the Green Light to Attack

T-cells. Credit: Zappys Technology Flickr

 
 
 
 

RELATED ARTICLES

360 New Disease Models Identified in Lab Mouse Study

News

The research, which generated over 20 million pieces of data, has found 360 new disease models and provides 28,406 new descriptions of the genes’ effects on mouse biology and disease.

READ MORE

FDA to Fast Track Designation for Pfizer and Lilly's Tanezumab

News

Global Phase 3 program is studying potential new treatment option for millions of people living with chronic pain associated with osteoarthritis and chronic low back pain.

READ MORE

Advanced Cancer Drug Study Highlights Need for Novel Approaches

News

The pre-clinical findings, just published in Cell Chemical Biology, may lay the foundation for improving therapies for treatment-resistant, aggressive prostate cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Applied Sciences Biopharma Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE